Literature DB >> 21992983

Validation of a dye stain assay for vaginally inserted hydroxyethylcellulose-filled microbicide applicators.

Lauren L Katzen1, José A Fernández-Romero, Avina Sarna, Kailapuri G Murugavel, Daniel Gawarecki, Thomas M Zydowsky, Barbara S Mensch.   

Abstract

BACKGROUND: The reliability and validity of self-reports of vaginal microbicide use are questionable given the explicit understanding that participants are expected to comply with study protocols. Our objective was to optimize the use of Population Council's previously validated dye stain assay (DSA) and related procedures, and to establish predictive values for the DSAs ability to identify vaginally inserted single-use, low-density polyethylene microbicide applicators filled with hydroxyethylcellulose gel.
METHODS: Applicators, inserted by 252 female sex workers enrolled in a microbicide feasibility study in Southern India, served as positive controls for optimization and validation experiments. Before validation, optimal dye concentration and staining time were ascertained. Three validation experiments were conducted to determine sensitivity, specificity, and negative and positive predictive values.
RESULTS: The dye concentration of 0.05% (wt/vol) FD&C Blue No. 1 Granular Food Dye (Prime Ingredients, Inc, Saddlebrook, NJ) and staining time of 5 seconds were determined to be optimal and were used for the 3 validation experiments. There were a total of 1848 possible applicator readings across validation experiments; 1703 (92.2%) applicator readings were correct. On average, the DSA performed with 90.6% sensitivity, 93.9% specificity, and had a negative predictive value of 93.8% and a positive predictive value of 91.0%. No statistically significant differences between experiments were noted.
CONCLUSIONS: The DSA was optimized and successfully validated for use with single use, low-density polyethylene applicators filled with hydroxyethylcellulose gel. We recommend including the DSA in future microbicide trials involving vaginal gels so as to identify participants who have low adherence to dosing regimens. In doing so, we can develop strategies to improve adherence as well as investigate the association between product use and efficacy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21992983      PMCID: PMC3210506          DOI: 10.1097/OLQ.0b013e31822e6160

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  25 in total

1.  In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials.

Authors:  Deborah Tien; Roger L Schnaare; Feirong Kang; Gina Cohl; Timothy J McCormick; Thomas R Moench; Gustavo Doncel; Karen Watson; Robert W Buckheit; Mark G Lewis; Jill Schwartz; Karen Douville; Joseph W Romano
Journal:  AIDS Res Hum Retroviruses       Date:  2005-10       Impact factor: 2.205

2.  Assessment of adherence to product dosing in a pilot microbicide study.

Authors:  Kathleen Hogarty; Andrea Kasowitz; Betsy C Herold; Marla J Keller
Journal:  Sex Transm Dis       Date:  2007-12       Impact factor: 2.830

3.  Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum Suppl       Date:  1987

4.  A comparison of three daily coital diary designs and a phone-in regimen.

Authors:  M A Hays; B Irsula; S L McMullen; P J Feldblum
Journal:  Contraception       Date:  2001-03       Impact factor: 3.375

5.  Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel.

Authors:  Barbara S Mensch; Paul C Hewett; Sharon Abbott; Johanna Rankin; Sarah Littlefield; Khatija Ahmed; Nazira Cassim; Smruti Patel; Gita Ramjee; Thesla Palanee; Stan Mierzwa; Stephanie Skoler-Karpoff
Journal:  AIDS Behav       Date:  2011-02

6.  Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study.

Authors:  Jill L Schwartz; Christine Mauck; Jaim-Jou Lai; Mitchell D Creinin; Vivian Brache; Susan A Ballagh; Debra H Weiner; Sharon L Hillier; Raina N Fichorova; Marianne Callahan
Journal:  Contraception       Date:  2006-05-02       Impact factor: 3.375

7.  Agreement between prospective interactive voice response self-monitoring and structured retrospective reports of drinking and contextual variables during natural resolution attempts.

Authors:  Jalie A Tucker; H Russell Foushee; Bethany C Black; David L Roth
Journal:  J Stud Alcohol Drugs       Date:  2007-07       Impact factor: 2.582

8.  Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials.

Authors:  Andrea R Wallace; Aaron Teitelbaum; Livia Wan; Maria Gloria Mulima; Laura Guichard; Stephanie Skoler; Stephanie Skiler; Hlengiwe Vilakazi; Fridda S Mapula; Jasmine Rossier; Sumen N Govender; Pekka Lahteenmaki; Robin A Maguire; David M Phillips
Journal:  Contraception       Date:  2007-05-11       Impact factor: 3.375

9.  Microbicides: stopping HIV at the gate.

Authors:  Alan Stone; Shibo Jiang
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

10.  SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

Authors:  Leigh Peterson; Kavita Nanda; Baafuor Kofi Opoku; William Kwabena Ampofo; Margaret Owusu-Amoako; Andrew Yiadom Boakye; Wes Rountree; Amanda Troxler; Rosalie Dominik; Ronald Roddy; Laneta Dorflinger
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

View more
  12 in total

Review 1.  Methodological lessons from clinical trials and the future of microbicide research.

Authors:  Ariane van der Straten; Elizabeth T Montgomery; Miriam Hartmann; Alexandra Minnis
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

2.  An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.

Authors:  Sharon A Abbott; Barbara A Friedland; Avina Sarna; Lauren L Katzen; Ulrike Rawiel; Aylur K Srikrishnan; C S Shalini; Waimar Tun; Christine A Kelly; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2013-07

3.  Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa.

Authors:  Ariane van der Straten; Elizabeth Montgomery; Diantha Pillay; Helen Cheng; Anushka Naidoo; Zakhele Cele; Kalendri Naidoo; Miriam Hartmann; Jeanna Piper; Gonasagrie Nair
Journal:  AIDS Behav       Date:  2013-02

4.  Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies.

Authors:  Wutyi S Aung; Rahul P Bakshi; Jennifer Breakey; James E Johnson; Craig W Hendrix; Ethel Weld; Edward J Fuchs; Mark A Marzinke
Journal:  AIDS Behav       Date:  2019-01

5.  Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations.

Authors:  Anke Hemmerling; William G Harrison; Joelle Morgan Brown; Barbara Moscicki; Maria Oziemkowska; Elizabeth A Bukusi; Craig R Cohen
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

6.  Assessment of a Microbicide Candidate among a Diverse Cohort of Urban Southern US Women and their Male Sexual Partners.

Authors:  Paula Frew; Kimberly Parker; Takeia Horton; Brooke Hixson; Lisa Flowers; Frances Priddy; Lisa Grohskopf; Christine Mauck; Kimberly Workowski
Journal:  J AIDS Clin Res       Date:  2012-07-03

7.  Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials.

Authors:  Ariane van der Straten; Helen Cheng; Barbara Mensch; Barbara Friedland; Lauren Katzen; Sarah Littlefield; Niall Buckley; Lilia Espinoza; Marla J Keller; Betsy C Herold; Mark H Einstein
Journal:  Sex Transm Dis       Date:  2013-12       Impact factor: 2.830

8.  Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex.

Authors:  Marla J Keller; Niall Buckley; Lauren L Katzen; Jennifer Walsh; Barbara Friedland; Sarah Littlefield; Juan Lin; Xiaonan Xue; Terri Cornelison; Betsy C Herold; Mark H Einstein
Journal:  Sex Transm Dis       Date:  2013-12       Impact factor: 2.830

9.  Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.

Authors:  Marla J Keller; Colleen A Carpenter; Yungtai Lo; Mark H Einstein; Congzhou Liu; David N Fredricks; Betsy C Herold
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

10.  Development of a composite measure of product adherence, protocol compliance, and semen exposure using DNA and protein biomarkers for topical HIV prevention studies.

Authors:  Terry A Jacot; Ashley Nelson; Andrea Thurman; Angela D M Kashuba; David F Archer; Gustavo F Doncel
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.